Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€31.08

€31.08

-1.310%
-0.41
-1.310%
€31.70
 
19.11.25 / Tradegate WKN: A2QMYY / Symbol: HIMS / Name: Hims & Hers Health / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Hims & Hers Health Inc. Stock

We can see a decrease in the price for Hims & Hers Health Inc.. Compared to yesterday it has lost -€0.410 (-1.310%).
Currently there is a rather positive sentiment for Hims & Hers Health Inc. with 16 Buy predictions and 12 Sell predictions.
However, we have a potential of -0.26% for Hims & Hers Health Inc. as the target price of 31 € is below the current price of 31.08 €.
For the coming years our community has positive and negative things to say abot the Hims & Hers Health Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Debt" there were negative voices in the community.

Pros and Cons of Hims & Hers Health Inc. in the next few years

Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01

The financial outlook for Hims & Hers Health (symbol: HIMS) presents an interesting tableau that mirrors the evolving landscape of the healthcare industry, particularly in the realm of telehealth and wellness services. At first glance, the company’s financials reflect both the potential for growth and the challenges that come with it. While the revenue growth shows promise, the profitability metrics raise some eyebrows. Here's a deeper dive into the pros and cons of the company's financial position.

1. Revenue Growth and Market Presence:

Hims & Hers has demonstrated impressive revenue growth, with a year-over-year quarterly revenue increase of approximately 45.8%. This growth trajectory signifies a strong market presence and an escalating demand for its digital health solutions. The total revenue stands at $959.4 million, highlighting the company’s ability to attract and retain a growing customer base in a competitive market.

Comments

Prediction Sell
Perf. (%) -21.99%
Target price 27.805
Change
Ends at 04.11.26

Hims & Hers Health (NYSE:HIMS) had its price target raised by analysts at Bank of America Corporation from $28.00 to $32.00. They now have an "underperform" rating on the stock.
Ratings data for HIMS provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -21.99%
Target price 73.857
Change
Ends at 04.11.26

Hims & Hers Health (NYSE:HIMS) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $85.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat
Show more

Hims & Hers Health, Inc. (NYSE: HIMS) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for HIMS provided by MarketBeat
Show more